These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3547807)

  • 41. [Implications of the immunologic response to the graft in the design of immunosuppressive treatment for liver transplantation].
    de la Mata M; Barrera P; Montero JL; Fraga E; Briceño J; Pozo JC; Solórzano G
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():52-6. PubMed ID: 15195535
    [No Abstract]   [Full Text] [Related]  

  • 42. [Regional results of human liver transplantation in Vienna].
    Piza F; Fritsch A; Funovics J; Kretschmer G; Mühlbacher F; Rauhs R; Roth E; Steininger R; Mauritz W; Sporn P
    Wien Klin Wochenschr; 1985 Sep; 97(18):714-9. PubMed ID: 3907154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients.
    Testa G; Crippin JS; Netto GJ; Goldstein RM; Jennings LW; Brkic BS; Brooks BK; Levy MF; Gonwa TA; Klintmalm GB
    Liver Transpl; 2000 Sep; 6(5):553-61. PubMed ID: 10980053
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety of minimal immunosuppression in liver transplantation for hepatoblastoma.
    Suh MY; Wang K; Gutweiler JR; Misra MV; Krawczuk LE; Jenkins RL; Lillehei CW; Jonas MM; Kim HB
    J Pediatr Surg; 2008 Jun; 43(6):1148-52. PubMed ID: 18558198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
    Pedrosa MC; Rohrer RM; Kaplan MM
    Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of intraportal donor-specific leukocyte transfusion for adult ABO-incompatible liver transplantation.
    Oya H; Sato Y; Yamamoto S; Nakatsuka H; Kobayashi T; Watanabe T; Hara Y; Kokai H; Hatakeyama K
    Transplant Proc; 2009; 41(1):222-5. PubMed ID: 19249519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Simultaneous liver-pancreas-duodenum transplantation: one case report and review of the literature].
    Xu J; Yu LX; Deng WF; Fu SJ; Du CF; Wang YB; Liu XY; Miao Y; Li CJ; Ye JS
    Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):157-60. PubMed ID: 16635342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Orthotopic liver transplantation: treatment of choice in cirrhotic patients with hepatocellular carcinoma?
    Moreno P; Jaurrieta E; Figueras J; Benasco C; Rafecas A; Fabregat J; Torras J; Casanovas T; Casais L
    Transplant Proc; 1995 Aug; 27(4):2296-8. PubMed ID: 7652813
    [No Abstract]   [Full Text] [Related]  

  • 49. Management of hepatocellular carcinoma in the age of liver transplantation.
    Martin AP
    Int J Surg; 2009 Aug; 7(4):324-9. PubMed ID: 19643691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation.
    Gibelli NE; Tannuri U; Mello ES; Cançado ER; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Pinho-Apezzato ML; Maksoud JG
    Pediatr Transplant; 2006 May; 10(3):371-6. PubMed ID: 16677364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Combined liver-kidney transplantation in a senior patient].
    Yu LX; Xu J; Deng WF; Li CJ; Ye GR; Fu SJ; Du CF; Ma JJ; Wang YB; Liu XY; Yao B
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):972-4. PubMed ID: 13129739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and experimental liver grafting.
    Calne RY
    Guys Hosp Rep; 1974; 123(1):1-12. PubMed ID: 4619101
    [No Abstract]   [Full Text] [Related]  

  • 53. Liver transplantation: current status.
    Williams R; MacDougall BR; Calne RY
    Compr Ther; 1982 May; 8(5):24-7. PubMed ID: 7047063
    [No Abstract]   [Full Text] [Related]  

  • 54. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
    Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
    Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Orthotopic liver transplantation (first clinical experience)].
    Konstantinov BA; Eramishantsev AK; Goté SV; Tsirulńikova OM; Skipenko OG; Lebezev VM; Shertsinger AG; Lokshin LS
    Khirurgiia (Mosk); 1993 Mar; (3):32-44. PubMed ID: 8089967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation.
    Fábrega E; López-Hoyos M; San Segundo D; Casafont F; Pons-Romero F
    Liver Transpl; 2009 Jun; 15(6):629-33. PubMed ID: 19479806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Towards minimizing immunosuppression in pediatric liver transplant recipients.
    Turmelle YP; Nadler ML; Anderson CD; Doyle MB; Lowell JA; Shepherd RW
    Pediatr Transplant; 2009 Aug; 13(5):553-9. PubMed ID: 19067920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence, timing, and risk factors for acute and chronic rejection.
    Neuberger J
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S30-6. PubMed ID: 10431015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunosuppressive effects of the orthotopically transplanted porcine liver.
    Calne RY; White HJ; Binns RM; Herbertson BM; Millard PR; Pena J; Salaman JR; Samuel JR; Davis DR
    Transplant Proc; 1969 Mar; 1(1):321-4. PubMed ID: 4944235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.